UPDATE 1-FDA approves Rockwell Medical's iron replacement drug

January 26, 2015 1:55 PM

8 0

Jan 26 (Reuters) - The U.S. Food and Drug Administration approved Rockwell Medical Inc's drug for treating iron loss in chronic kidney disease patients on dialysis, sending the company's shares up about 15 percent in premarket trading.

The drug, Triferic, replaces the 5-7 mg of iron patients tend to lose during each dialysis session.

Also watch: Raiders' Derek Carr signs new five-year deal worth $125 million

Read more

To category page

Loading...